Richard Gordon Daniell — Executive Vice President of European Commercial at Teva Pharmaceutical Industries Limited

Mr. Richard Gordon Daniell has been Executive Vice President of European Commercial at Teva Pharmaceutical Industries Limited since November 27, 2017. Mr. Daniell has been President and Chief Executive Officer at Teva Generics Europe since December 2016. Mr. Daniell served as Managing Director at Teva UK Ltd., and was responsible for all Teva's commercial activities in the UK. Mr. Daniell has a wealth of experience in the pharmaceutical industry; having amassed more than two decades of knowledge in Teva group companies. He served as Commercial Operations Officer of Teva UK Ltd., since 2009. He served as Chief Integration Officer Leading Actavis-Teva Integration since September 2015 after holding various senior roles, including Chief Operating Officer of Growth Markets and Regional General Manager for Teva in the UK and Ireland from 2012 through 2014. Mr. Daniell joined Teva as Senior Director Teva UK Limited in 2006, following the acquisition of IVAX Pharmaceuticals UK. Prior to joining Teva, he served three years at IVAX Pharmaceuticals UK as Director of Generics. Mr. Daniell received his BSc in chemistry from the University of Auckland.